Literature DB >> 2140288

Propranolol and depression: evidence from the antihypertensive trials.

S B Patten1.   

Abstract

The relationship between propranolol and depression is a subject of controversy. Numerous case reports suggest that propranolol can cause depression, but two small prospective trials have failed to confirm this. The contemporary psychiatric literature is divided as to whether propranolol can cause depression. This study addresses this issue by re-analyzing side effect data from clinical trials of propranolol as an antihypertensive agent. A literature review was carried out and the data were analyzed using meta-analytic statistical techniques. Propranolol was found to cause depression as a side effect with a statistically greater frequency than the control medications used in these trials. As other side effects of propranolol include fatigue, diminished energy, decreased libido, anorexia and poor concentration, it is suggested that propranolol is a cause of organic mood disorder, depressed type.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140288     DOI: 10.1177/070674379003500312

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  10 in total

1.  Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.

Authors:  H T Sørensen; L Mellemkjaer; J H Olsen
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

Review 2.  Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.

Authors:  Ana Franky Carvalho; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-24       Impact factor: 5.067

Review 3.  On the physiology of metazoa.

Authors:  A R Ameen
Journal:  Experientia       Date:  1996-03-15

4.  Acute effects of beta blockade and exercise on mood and anxiety.

Authors:  A Head; M J Kendall; R Ferner; C Eagles
Journal:  Br J Sports Med       Date:  1996-09       Impact factor: 13.800

5.  Anxiety and depression symptoms in arterial hypertension: the influence of antihypertensive treatment. the HUNT study, Norway.

Authors:  Aslak Johansen; Jostein Holmen; Robert Stewart; Ottar Bjerkeset
Journal:  Eur J Epidemiol       Date:  2011-12-20       Impact factor: 8.082

6.  Cardiovascular drugs and the risk of suicide: a nested case-control study.

Authors:  Torbjörn Callréus; Ulla Agerskov Andersen; Jesper Hallas; Morten Andersen
Journal:  Eur J Clin Pharmacol       Date:  2007-03-20       Impact factor: 2.953

7.  Effects of long-term psychological intervention on blood pressure and health-related quality of life in patients with hypertension among the Chinese working population.

Authors:  Lei Liu; Min Li; Shaowu Song; Anshi Shi; Si Cheng; Xiawei Dang; Hui Chen; Heng Zhang; A Ziguli; Lifei Cao; Ping Wang; Hui Luan; Yunlong Ma; Songlin Zhang; Zengwu Wang; Xin Wang; Runlin Gao; Gang Tian
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

Review 8.  Neuropsychiatric consequences of cardiovascular medications.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

9.  Depressogenic medications and other risk factors for depression among Polish patients with epilepsy.

Authors:  Magdalena Bosak; Wojciech Turaj; Dominika Dudek; Marcin Siwek; Andrzej Szczudlik
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-30       Impact factor: 2.570

10.  Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes.

Authors:  Gaetano Santulli; Guido Iaccarino
Journal:  Immun Ageing       Date:  2013-03-15       Impact factor: 6.400

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.